About
Principal at RiverVest who discusses the biology of neurodegenerative disease and how advances in RNA biology may enable disease-modifying interventions.
Experience
- RiverVest Venture PartnersPrincipalcurrent2023 β present
- RiverVest Venture PartnersSenior Associate2021 β 2023
- BiolinqBoard Membercurrent2026 β present
- Bluejay TherapeuticsMember Board of Directors2023 β 2026
- Bluejay TherapeuticsBoard Observer2021 β 2023
- Holoclara, IncBoard of Directors2019 β 2021
- NVascBoard of Directors2019 β 2021
- Linnaeus TherapeuticsBoard of Directors2019 β 2021
- Kairos VenturesInvestment Associate2017 β 2021Greater Los Angeles Area
- UCLA Business of Science CenterContract Consultant2015 β 2017Greater Los Angeles Area
- UC IrvineJunior Specialist2010 β 2011Developmental Biology Center
- University of California, IrvineUndergraduate Research Assistant2006 β 2010Department of Developmental and Cell Biology
Education
- UC IrvineB.S., Developmental and Cell Biology
- UCLAPhD, Molecular Biology (Biophysics
Skills & more
Biochemistry16Cell Biology6Molecular Cloning9Molecular Biology15Protein Purification8Cell Culture3qPCR1Protein Expression4Cell Signaling1Scientific Writing2RNA isolation1Polymerase Chain Reaction (PCR)1
+3 more
Protein ChemistryResearchScienceFrom Pascal's professional profile.
Same school
Also attended UC Irvine89
Christian BuergerPortfolio Development at Intel CapitalJonathan GiegCommunity Manager at Pantera CapitalRyan LaurinManaging Director at Marlin Equity PartnersZack IsaacsonVenture Partner at Rackhouse Venture Management LpCameron BaharVenture Partner at Think+ Ventures Management, LlcTanya WesleyInvestor at TRANSFORMATION CAPITAL
+ 83 more
Also attended UCLA403
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzRon ConwayFounder of SV AngelKirsten GreenFounder and Managing Partner at Forerunner VenturesPaul FieldingFinance & Operations at General CatalystMelody MaExecutive Assistant and Lead Receptionist at Trinity VenturesGizem CakilInvestor at OpenView Venture Partners
+ 397 more
Shared employers
Also worked at RiverVest Venture Partners9
Jay W. SchmelterCo-founder at RiverVest Venture PartnersJohn McKearnSenior Advisor at RiverVest Venture Partners, focused on early-stage biotechNiall O'DonnellPh.D. at RiverVest Venture PartnersKaren SpilizewskiManaging Director at RiverVest Venture PartnersDerek RappInvestor at RiverVest Venture PartnersAndrew KleiboekerAssociate at RiverVest Venture Partners
+ 3 more
Also worked at Biolinq7
Alexander HoffmannGeneral Partner at ForbionSonny VuManaging Partner at AlabasterDaniel BradburyInvestor at BioBritRob ChaplinskyCo-Founder & Managing Director at Link VenturesDaniel FrankePrincipal at M VenturesPascal KroteeSenior Associate at RiverVest Venture
+ 1 more
Also worked at Bluejay Therapeutics1
Also worked at Holoclara, Inc2
Colleagues at RiverVest Venture Partners
Alessandro Sette
Scientific Advisor; Professor and Member, La Jolla Institute for Immunology at RiverVest Venture Partners
Andrew Kleiboeker
Associate at RiverVest Venture Partners
Andy Craig
Co-founder at RiverVest Venture Partners
Corrin Short
Executive Assistant at RiverVest Venture Partners
Courtney Harris
Controller at RiverVest Venture Partners
Derek Rapp
Investor at RiverVest Venture Partners
Gary DeCrescenzo
Scientific Advisor; Independent Consultant, Pharmaceutical Research and Development at RiverVest Venture Partners
Isaac Zike
Managing Director, Ph.D. at RiverVest Venture Partners





















